Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Tuberkuloz Ve Toraks|August 16, 2019
An autopsied NSCLC patient with huge adrenal gland metastasis with rapid growth and local invasionSatoshi Hagimoto, Kunihiko Miyazaki, Shinya Sato, et al.
The American Journal of Hospice & Palliative Care|February 11, 2026
Nationwide Survey of Physician's Attitudes Toward Palliative Care for Patients in the ICU in JapanHaruka Harano, Yusuke Miyoshi, Yuko Igarashi, et al.
Respiratory Investigation|March 26, 2026
Helmet noninvasive ventilation in patients with COVID-19-related acute hypoxemic respiratory failure: A Japanese single-center experienceToshiki Yokoyama, Ryo Teramachi, Kaho Hiramitsu, et al.
Respiratory Investigation|November 21, 2025
Psychological palliative care for patients with interstitial lung disease in Japan: A secondary analysis of a National Survey of Japanese Respiratory PhysiciansYoshinobu Matsuda, Tomoyuki Fujisawa, Tatsuya Morita, et al.
Respiratory Research|October 30, 2022
End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbationNorimichi Akiyama, Tomoyuki Fujisawa, Tatsuya Morita, et al.
Respirology (Carlton, Vic.)|March 22, 2023
Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialistsTomoyuki Fujisawa, Norimichi Akiyama, Tatsuya Morita, et al.
Microbiology Spectrum|February 10, 2026
Diagnostic utility of quantitative interferon-gamma release assays in elderly patients with tuberculosisYoshikazu Mutoh, Yusuke Minato, Yuya Kawamoto, et al.
Respiratory Investigation|May 15, 2026
Reliability, validity, responsiveness, and minimal important difference of the St. George's Respiratory Questionnaire in patients with idiopathic pleuroparenchymal fibroelastosisYuta Mori, Toshiaki Matsuda, Atsushi Suzuki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 12, 2026
Matching-adjusted comparison of the effectiveness and safety of Ensitrelvir versus Remdesivir for high-risk, hospitalized patients with non-severe COVID-19 in JapanYoshikazu Mutoh, Toshiyuki Yamaguchi, Koki Sakurai, et al.
Viruses|March 30, 2023
Real-World Experience of the Comparative Effectiveness and Safety of Molnupiravir and Nirmatrelvir/Ritonavir in High-Risk Patients with COVID-19 in a Community SettingYoshikazu Mutoh, Takumi Umemura, Takeshi Nishikawa, et al.
Pageof 2